Heron Therapeuti (HRTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.20
• Market Cap: $198.03M
• EPS: $-0.09
• 52-Week High: $2.68
• 52-Week Low: $1.00

Market Sentiment

Heron Therapeuti currently has a Neutral sentiment score of 0.13.

About Heron Therapeuti

Heron Therapeutics, Inc. (HRTX), based in San Diego, California, is a biotechnology company dedicated to developing innovative therapies that address substantial unmet medical needs in pain management and antiemetic care. The firm specializes in the research and commercialization of novel pharmaceutical products aimed at enhancing the quality of life for patients undergoing surgical procedures and cancer treatments. With a robust pipeline and a strategic focus on high-demand therapeutic areas...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Heron Therapeuti and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does HRTX pay dividends?

Heron Therapeuti (HRTX) does not currently pay a regular dividend.

What is HRTX's market cap?

Heron Therapeuti (HRTX) has a market capitalization of $198.03M with a current stock price of $1.20.